Ganga Pharmaceuticals Ltd.
| BSE: 539680 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE615T01017 |
| BSE 00:00 | 02 Feb | 7.50 |
0 (0.00%) |
OPEN
7.50 |
HIGH
7.50 |
LOW
7.50 |
| NSE 05:30 | 01 Jan | Ganga Pharmaceuticals Ltd |
| OPEN | 7.50 |
| PREVIOUS CLOSE | 7.50 |
| VOLUME | 8000 |
| 52-Week high | 12.00 |
| 52-Week low | 7.00 |
| P/E | 16.30 |
| Mkt Cap.(Rs cr) | 3 |
| Buy Price | 8.64 |
| Buy Qty | 8000.00 |
| Sell Price | 9.00 |
| Sell Qty | 8000.00 |
Ganga Pharmaceuticals Ltd. (GANGAPHARMA) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Sun Pharma.Inds. | 602.55 | -1.50 | -0.25 | 3211.14 |
| Dr Reddy's Labs | 4441.50 | -47.60 | -1.06 | 2937.70 |
| Cipla | 789.55 | -1.35 | -0.17 | 2318.17 |
| Aurobindo Pharma | 862.15 | 6.15 | 0.72 | 1872.74 |
| Cadila Health. | 433.90 | 3.50 | 0.81 | 1412.90 |
| Divi's Lab. | 3483.10 | 33.80 | 0.98 | 1372.71 |
| Glenmark Pharma. | 466.40 | -0.85 | -0.18 | 1354.55 |
| Alkem Lab | 2765.40 | 39.75 | 1.46 | 1264.42 |
| Alembic Pharma | 884.70 | -7.95 | -0.89 | 969.40 |
| Torrent Pharma. | 2476.35 | 50.80 | 2.09 | 938.51 |
| Gland Pharma | 2367.10 | -14.20 | -0.60 | 772.86 |
| Lupin | 1007.60 | -3.00 | -0.30 | 727.55 |
| Ipca Labs. | 1868.00 | 66.10 | 3.67 | 652.46 |
| Abbott India | 14582.40 | 107.25 | 0.74 | 592.93 |
| Fortis Health. | 161.00 | -1.40 | -0.86 | 513.33 |
| Pfizer | 4484.55 | 28.60 | 0.64 | 509.13 |
| Natco Pharma | 806.25 | -12.50 | -1.53 | 474.50 |
| Apollo Hospitals | 3058.25 | 60.90 | 2.03 | 470.30 |
| Granules India | 325.80 | 3.95 | 1.23 | 444.07 |
| Ajanta Pharma | 1749.75 | 6.50 | 0.37 | 441.13 |
Quick Links for Ganga Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
